Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Singtel to Sell Bharti Airtel Stake Worth ₹10,300 Crore; Company Posts Strong Q2 Results

Telecom

|

Updated on 06 Nov 2025, 01:06 pm

Whalesbook Logo

Reviewed By

Simar Singh | Whalesbook News Team

Short Description:

Singapore Telecommunications Ltd (Singtel) is planning to offload approximately 0.8% of its stake in Bharti Airtel Ltd through a block deal estimated at ₹10,300 crore, with a floor price of ₹2,030 per share. This comes as Bharti Airtel reported robust financial results for the July-September quarter (Q2 FY26), with a consolidated net profit of ₹6,791 crore, a 14.2% increase quarter-on-quarter, and revenue growing to ₹52,145 crore.
Singtel to Sell Bharti Airtel Stake Worth ₹10,300 Crore; Company Posts Strong Q2 Results

▶

Stocks Mentioned:

Bharti Airtel Ltd

Detailed Coverage:

Singapore Telecommunications Ltd (Singtel) is reportedly looking to sell around 0.8% of its stake in Indian telecom giant Bharti Airtel Ltd. The transaction is expected to be a block deal valued at approximately ₹10,300 crore. Sources indicate that the floor price for the sale is set at ₹2,030 per share, which represents a 3.1% discount to the current market price. The deal could be executed either via an Offer for Sale (OFS) or a direct block trade.

This potential stake sale follows a similar transaction on August 8, where Indian Continent Investment, another promoter entity of Bharti Airtel, sold about 1% of its shareholding for roughly ₹11,200 crore. That placement saw strong demand from domestic and international long-only investors.

Separately, Bharti Airtel announced its financial results for the second quarter of the fiscal year 2026 (July-September). The company posted a consolidated net profit of ₹6,791 crore, showing a healthy 14.2% rise from the previous quarter and exceeding analyst expectations. Revenue for the quarter climbed 5.4% sequentially to ₹52,145 crore, also surpassing street estimates.

Impact This news could lead to short-term volatility in Bharti Airtel's stock price due to the large stake sale. However, the strong Q2 financial performance provides a positive fundamental backdrop. The sale by a major shareholder might be perceived as profit-taking or a strategic reallocation of assets by Singtel, but the underlying business strength indicated by the results is a positive sign for investors. The market will closely watch the execution of the block deal and its reception by institutional investors. Rating: 7/10

Difficult Terms Explained: Block Deal: A block deal is a large transaction of shares traded between two parties, often institutions, outside of the regular trading order book. It's usually done at a negotiated price. Offer for Sale (OFS): A method by which promoters or large shareholders of a listed company can sell their shares to the public through a stock exchange mechanism. It allows for large stake sales in a structured manner. Floor Price: The minimum price at which shares can be sold in an Offer for Sale or auction. Sellers cannot accept bids below this price.


Healthcare/Biotech Sector

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions


International News Sector

India and Australia Eye Early Conclusion of Phase 2 Trade Pact (CECA)

India and Australia Eye Early Conclusion of Phase 2 Trade Pact (CECA)

India and Australia Eye Early Conclusion of Phase 2 Trade Pact (CECA)

India and Australia Eye Early Conclusion of Phase 2 Trade Pact (CECA)